Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP
https://classic.clinicaltrials.gov/ct2/show/NCT05690204
WEBJan 19, 2023 · A Phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to assess the safety, PK, PD, and efficacy of 3 orally administered dosages of SAP-001 (10 mg QD, 30 mg QD, and 60 mg QD) compared to placebo QD in adult subjects with gout, with or without tophi, and hyperuricemia refractory to standard …
DA: 6 PA: 13 MOZ Rank: 55 Up or Down: Up